Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes

被引:82
作者
Costello, Fiona [1 ]
Hodge, William [2 ]
Pan, Y. Irene [2 ]
Freedman, Mark [3 ]
DeMeulemeester, Christine [3 ]
机构
[1] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[2] Univ Western Ontario, London, ON, Canada
[3] Univ Ottawa, Ottawa, ON, Canada
关键词
Retinal nerve fiber layer; Optic neuritis; Axonal atrophy; Multiple sclerosis; OPTICAL COHERENCE TOMOGRAPHY; DIAGNOSTIC-CRITERIA; AXONAL LOSS; NEURITIS; THICKNESS; IMPAIRMENT; MS;
D O I
10.1016/j.jns.2009.02.354
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To determine whether retinal nerve fiber layer (RNFL) atrophy in the afferent visual pathway may complement existing tools used to describe and characterize differences across MS subtypes. Methods: Optical coherence tomography-measured RNFL values were compared over two years in 35 patients (70 eyes) with optic neuritis (ON) as a clinically isolated syndrome (CIS): 39 patients (78 eyes) with relapsing remitting MS (RRMS); and 7 patients (14 eyes) with secondary progressive MS (SPMS). Results: RNFL comparisons involving eyes without ON yielded greater differences between MS subtypes than ON-affected eyes. Overall RNFL values in non-affected eyes were reduced in SPMS patients (83.4 W), relative to CIS (101.2 mu m) (p = 0.0009), and RRMS patients (103.7 mu m) (p = 0.001); and temporal RNFL atrophy was greater in RRMS (64.4 mu m) eyes as compared to CIS eyes (73.2 mu m) (p = 0.02). In ON-affected eyes, RNFL atrophy was greater in SPMS patients (39.5 mu m) than CIS patients (58.1 mu m) (p = 0.03), and in RRMS patients (48.2 mu m) relative to CIS patients (p=0.05). RNFL values did not change significantly for any MS subtype during the two-year duration of the study. Interpretation: RNFL thickness may represent a structural marker, which can help distinguish MS subtypes, because the extent of atrophy is commensurate with disease progression. RNFL comparisons between non-affected eyes revealed greater differences between CIS, RRMS, and SPMS patients relative to ON-affected eyes, because the impact of prior ON may supplant the effects of disease subtype. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:74 / 79
页数:6
相关论文
共 24 条
[1]  
Baumal C R, 1999, Curr Opin Ophthalmol, V10, P182, DOI 10.1097/00055735-199906000-00006
[2]   Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography [J].
Costello, F. ;
Hodge, W. ;
Pan, Y. I. ;
Eggenberger, E. ;
Coupland, S. ;
Kardon, R. H. .
MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (07) :893-905
[3]   Quantifying tonal loss after optic neuritis with optical coherence tomography [J].
Costello, F ;
Coupland, S ;
Hodge, W ;
Lorello, GR ;
Koroluk, J ;
Pan, YI ;
Freedman, MS ;
Zackon, DH ;
Kardon, RH .
ANNALS OF NEUROLOGY, 2006, 59 (06) :963-969
[4]  
ELBOL P, 1990, ACTA OPHTHALMOL, V68, P481
[5]   NEW VISUAL-ACUITY CHARTS FOR CLINICAL RESEARCH [J].
FERRIS, FL ;
KASSOFF, A ;
BRESNICK, GH ;
BAILEY, I .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1982, 94 (01) :91-96
[6]   Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis [J].
Fisher, JB ;
Jacobs, DA ;
Markowitz, CE ;
Galetta, SL ;
Volpe, NJ ;
Nano-Schiavi, ML ;
Baier, ML ;
Frohman, EM ;
Winslow, H ;
Frohman, TC ;
Calabresi, PA ;
Maguire, MG ;
Cutter, GR ;
Balcer, LJ .
OPHTHALMOLOGY, 2006, 113 (02) :324-332
[7]   INSIDIOUS ATROPHY OF RETINAL NERVE-FIBERS IN MULTIPLE-SCLEROSIS - FUNDUSCOPIC IDENTIFICATION IN PATIENTS WITH AND WITHOUT VISUAL COMPLAINTS [J].
FRISEN, L ;
HOYT, WF .
ARCHIVES OF OPHTHALMOLOGY, 1974, 92 (02) :91-97
[8]   An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography [J].
Henderson, Andrew P. D. ;
Trip, S. Anand ;
Schlottmann, Patricio G. ;
Altmann, Daniel R. ;
Garway-Heath, David F. ;
Plant, Gordon T. ;
Miller, David H. .
BRAIN, 2008, 131 :277-287
[9]   OPTICAL COHERENCE TOMOGRAPHY [J].
HUANG, D ;
SWANSON, EA ;
LIN, CP ;
SCHUMAN, JS ;
STINSON, WG ;
CHANG, W ;
HEE, MR ;
FLOTTE, T ;
GREGORY, K ;
PULIAFITO, CA ;
FUJIMOTO, JG .
SCIENCE, 1991, 254 (5035) :1178-1181
[10]   Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes [J].
Kappos, L. ;
Polman, C. H. ;
Freedman, M. S. ;
Edan, G. ;
Hartung, H. P. ;
Miller, D. H. ;
Montalban, X. ;
Barkhof, F. ;
Bauer, L. ;
Jakobs, P. ;
Pohl, C. ;
Sandbrink, R. .
NEUROLOGY, 2006, 67 (07) :1242-1249